553 related articles for article (PubMed ID: 31364245)
1. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
[TBL] [Abstract][Full Text] [Related]
2. The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University.
Kamat NV; Million L; Yao DH; Donaldson SS; Mohler DG; van de Rijn M; Avedian RS; Kapp DS; Ganjoo KN
Am J Clin Oncol; 2019 Feb; 42(2):166-171. PubMed ID: 30557163
[TBL] [Abstract][Full Text] [Related]
3. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
4. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
Massi D; Beltrami G; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology.
Ozcelik M; Seker M; Eraslan E; Koca S; Yazilitas D; Ercelep O; Ozaslan E; Kaya S; Hacibekiroglu I; Menekse S; Aksoy A; Taskoylu BY; Varol U; Arpaci E; Ciltas A; Oksuzoglu B; Zengin N; Gumus M; Aliustaoglu M
Tumour Biol; 2016 Apr; 37(4):5231-7. PubMed ID: 26553363
[TBL] [Abstract][Full Text] [Related]
6. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
[TBL] [Abstract][Full Text] [Related]
7. MFH and high-grade undifferentiated pleomorphic sarcoma-what's in a name?
Delisca GO; Mesko NW; Alamanda VK; Archer KR; Song Y; Halpern JL; Schwartz HS; Holt GE
J Surg Oncol; 2015 Feb; 111(2):173-7. PubMed ID: 25219789
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment and prognosis in patients with high-grade soft tissue malignant fibrous histiocytoma of the extremities.
Vasileios KA; Eward WC; Brigman BE
Arch Orthop Trauma Surg; 2012 Jul; 132(7):955-61. PubMed ID: 22487849
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
[TBL] [Abstract][Full Text] [Related]
10. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy.
Zagars GK; Mullen JR; Pollack A
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):983-94. PubMed ID: 8600111
[TBL] [Abstract][Full Text] [Related]
11. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
Khanfir K; Alzieu L; Terrier P; Le Péchoux C; Bonvalot S; Vanel D; Le Cesne A
Eur J Cancer; 2003 Sep; 39(13):1872-80. PubMed ID: 12932665
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive factors in undifferentiated pleomorphic sarcoma: A long-term study from a large tertiary care urban center.
Gonzalez MR; Clunk MJ; Bedi ADS; Werenski JO; Lang JH; Karczewski D; Sodhi A; Lozano-Calderon SA
J Surg Oncol; 2023 Aug; 128(2):322-331. PubMed ID: 37042427
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
Smith KB; Indelicato DJ; Knapik JA; Lagmay JP; Morris C; Kirwan JM; Zlotecki RA; Scarborough MT; Gibbs CP; Marcus RB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):150-7. PubMed ID: 21550181
[TBL] [Abstract][Full Text] [Related]
16. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal sarcomatosis due to undifferentiated pleomorphic sarcoma: A case report and review of the literature.
Sogutcu N; Kavak S; Gumus S
Indian J Pathol Microbiol; 2023; 66(2):356-359. PubMed ID: 37077083
[TBL] [Abstract][Full Text] [Related]
18. The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions.
Lee K; Song JS; Kim JE; Kim W; Song SY; Lee MH; Chung HW; Cho KJ; Lee JS; Ahn JH
Eur J Surg Oncol; 2020 Jul; 46(7):1287-1293. PubMed ID: 32127249
[TBL] [Abstract][Full Text] [Related]
19. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure.
Gronchi A; Miceli R; Fiore M; Collini P; Lozza L; Grosso F; Mariani L; Casali PG
Ann Surg Oncol; 2007 May; 14(5):1583-90. PubMed ID: 17260106
[TBL] [Abstract][Full Text] [Related]
20. Oncological outcome of patients with deeply located soft tissue sarcoma of the pelvis: a follow up study at minimum 5 years after diagnosis.
Nakamura T; Abudu A; Murata H; Grimer RJ; Carter SR; Tillman RM; Jeys L
Eur J Surg Oncol; 2013 Sep; 39(9):1030-5. PubMed ID: 23347778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
